Patents Assigned to THERALOGICS, INC.
  • Methods of treating muscular wasting diseases using NF-KB activation inhibitors
    Patent number: 9173920
    Abstract: Methods for treating muscular wasting diseases such as Duchenne muscular dystrophy are disclosed. Specifically, the methods include administering to a subject in need of treatment for a muscular wasting disease, an NF-?B activation inhibitor capable of blocking the activation of NF-?B.
    Type: Grant
    Filed: April 22, 2013
    Date of Patent: November 3, 2015
    Assignee: TheraLogics, Inc.
    Inventors: Denis C. Guttridge, Albert S. Baldwin
  • METHODS OF TREATING MUSCULAR WASTING DISEASES USING NF-KB ACTIVATION INHIBITORS
    Publication number: 20140005127
    Abstract: Methods for treating muscular wasting diseases such as Duchenne muscular dystrophy are disclosed. Specifically, the methods include administering to a subject in need of treatment for a muscular wasting disease, an NF-?B activation inhibitor capable of blocking the activation of NF-?B.
    Type: Application
    Filed: April 22, 2013
    Publication date: January 2, 2014
    Applicant: THERALOGICS, INC.
    Inventors: Denis C. Guttridge, Albert S. Baldwin
  • Methods of treating muscular wasting diseases using NF-?B activation inhibitors
    Patent number: 8426355
    Abstract: Methods for treating muscular wasting diseases such as Duchenne muscular dystrophy are disclosed. Specifically, the methods include administering to a subject in need of treatment for a muscular wasting disease, an NF-?B activation inhibitor capable of blocking the activation of NF-?B.
    Type: Grant
    Filed: March 15, 2007
    Date of Patent: April 23, 2013
    Assignee: TheraLogics, Inc.
    Inventors: Denis C. Guttridge, Albert S. Baldwin
  • Methods of Treating Muscular Wasting Diseases Using NF-kB Activation Inhibitors
    Publication number: 20070225315
    Abstract: Methods for treating muscular wasting diseases such as Duchenne muscular dystrophy are disclosed. Specifically, the methods include administering to a subject in need of treatment for a muscular wasting disease, an NF-?B activation inhibitor capable of blocking the activation of NF-?B.
    Type: Application
    Filed: March 15, 2007
    Publication date: September 27, 2007
    Applicant: THERALOGICS, INC.
    Inventors: Denis Guttridge, Albert Baldwin